KRISTIN TURMEL: Open Payments
NPI 1669092300 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,877 in 202 payments from 23 companies in 2025. Trend: 2023 $3,112 · 2024 $3,482 · 2025 $3,877
Food & beverage: $3,491Education: $386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $729 |
| Novartis Pharmaceuticals Corporation | 20 | $500 |
| GENZYME CORPORATION | 12 | $393 |
| UCB, Inc. | 27 | $330 |
| Janssen Biotech, Inc. | 9 | $275 |
| PFIZER INC. | 17 | $248 |
| Regeneron Healthcare Solutions, Inc. | 11 | $240 |
| Galderma Laboratories, L.P. | 14 | $176 |
| SANOFI-AVENTIS U.S. LLC | 2 | $162 |
| Lilly USA, LLC | 5 | $127 |
Products named: DUPIXENT, RINVOQ, Bimzelx, COSENTYX, TREMFYA, SKYRIZI, CIBINQO, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
